Massive study sheds light on liver surgery for rare cancers
NCT ID NCT07180641
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed study looked back at over 1,000 patients who had liver surgery for cancers that started elsewhere in the body (not colorectal). Researchers tracked survival and complications to learn what works best. The goal is to create better treatment recommendations for these complex cases.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide clearer guidelines for treating liver metastases from cancers other than colorectal cancer.
- What could go wrong
- This is an observational study, not a trial of a new treatment. It cannot prove what works best, only describe past outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
1,039 people
The number who actually took part.
- Started
-
Jan 2010
- Finished
-
Dec 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients scheduled for liver surgery due to non-colorectal liver metastases, regardless of the primary tumor origin, via open or minimally invasive approach, from January 2010 to December 2022
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients scheduled for liver surgery due to non-colorectal liver metastases, regardless of the primary tumor origin, via open or minimally invasive approach Exclusion Criteria: * Patients undergoing surgery for colorectal liver metastases, emergency surgical interventions and patients younger than 18 years old.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hepatectomy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can zapping liver and lung tumors boost treatment for nasopharyngeal cancer?
- Can watching kidney oxygen during liver surgery keep kidneys safe?
- Can a Pressure-Sensitive catheter sharpen Radiation's aim at liver tumors?
- A new anesthesia drug may keep blood pressure steadier during liver surgery
- Can removing liver tumors alongside the whipple procedure extend life in stage IV pancreatic cancer?
- Mapping tumors in 3D: could imaging reveal hidden growth patterns?